Furthermore, therapy with GLP1-RA is associated with a potentiation of glucose induced insulin secretion and a modest weight loss [13] and as a result it effectively reduces hyperglycemia in patients with T2DM [14]. The gene discussed is INS; the disease is type 2 diabetes mellitus.